DRTS vs. PROF, OBIO, CLPT, QIPT, ARAY, UTMD, TLSI, STIM, INO, and ANGO
Should you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Profound Medical (PROF), Orchestra BioMed (OBIO), ClearPoint Neuro (CLPT), Quipt Home Medical (QIPT), Accuray (ARAY), Utah Medical Products (UTMD), TriSalus Life Sciences (TLSI), Neuronetics (STIM), Inovio Pharmaceuticals (INO), and AngioDynamics (ANGO). These companies are all part of the "surgical & medical instruments" industry.
Alpha Tau Medical (NASDAQ:DRTS) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, community ranking, risk, valuation, dividends, earnings and analyst recommendations.
2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profound Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.
Alpha Tau Medical currently has a consensus target price of $12.00, indicating a potential upside of 346.10%. Profound Medical has a consensus target price of $14.58, indicating a potential upside of 86.73%. Given Alpha Tau Medical's higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than Profound Medical.
Alpha Tau Medical has a net margin of 0.00% compared to Profound Medical's net margin of -396.85%. Alpha Tau Medical's return on equity of -31.86% beat Profound Medical's return on equity.
Profound Medical received 26 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 71.15% of users gave Profound Medical an outperform vote while only 57.89% of users gave Alpha Tau Medical an outperform vote.
In the previous week, Profound Medical had 4 more articles in the media than Alpha Tau Medical. MarketBeat recorded 5 mentions for Profound Medical and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 0.42 beat Profound Medical's score of 0.19 indicating that Alpha Tau Medical is being referred to more favorably in the media.
Alpha Tau Medical has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.
Summary
Profound Medical beats Alpha Tau Medical on 9 of the 17 factors compared between the two stocks.
Get Alpha Tau Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Tau Medical Competitors List
Related Companies and Tools
